Linzess

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA202811 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Linzess® Is Indicated In Adults For The Treatment Of: Irritable Bowel Syndrome With Constipation (Ibs-C) Chronic Idiopathic Constipation (Cic). Linzess Is A Guanylate Cyclase-C Agonist Indicated In Adults For Treatment Of: Irritable Bowel Syndrome With Constipation. (Ibs-C) ( 1 ) Chronic Idiopathic Constipation. (Cic) ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Linaclotide

Comments